EBioMedicine · 2020 · 31 citations · 29 references
Life SciencesCardiologyGeneticsGenomicsHuman GeneticsMedical GeneticsGenetic DisordersGenetic SyndromesHypertrophic Cardiomyopathy GeneticsInherited Arrhythmia SyndromesInherited CardiomyopathiesSudden Cardiac Death GeneticsCardiac Conduction AbnormalitiesClinical Next-generation SequencingFamilial Cardiomyopathy GeneticsGenetic PenetranceIncomplete PenetranceParoxysmal Supraventricular TachycardiaSudden Cardiac Death PredispositionTargeted Next-generation Sequencing
BACKGROUND: Although 21 causative mutations have been associated with PRKAG2 syndrome, our understanding of the syndrome remains incomplete. The aim of this project is to further investigate its unique genetic background, clinical manifestations, and underlying structural changes. METHODS: We recruited 885 hypertrophic cardiomyopathy (HCM) probands and their families internationally. Targeted next-generation sequencing of sudden cardiac death (SCD) genes was performed. The role of the identified variants was assessed using histological techniques and computational modeling. FINDINGS: Twelve PRKAG2 syndrome kindreds harboring 5 distinct variants were identified. The clinical penetrance of 25 carriers was 100.0%. Twenty-two family members died of SCD or heart failure (HF). All probands developed bradycardia (HRmin, 36.3 ± 9.8 bpm) and cardiac conduction defects, and 33% had evidence of atrial fibrillation/paroxysmal supraventricular tachycardia (PSVT) and 67% had ventricular preexcitation, respectively. Some carriers presented with apical hypertrophy, hypertension, hyperlipidemia, and renal insufficiency. Histological study revealed reduced AMPK activity and major cardiac channels in the heart tissue with K485E mutation. Computational modelling suggests that K485E disrupts the salt bridge connecting the β and γ subunits of AMPK, R302Q/P decreases the binding affinity for ATP, T400N and H401D alter the orientation of H383 and R531 residues, thus altering nucleotide binding, and N488I and L341S lead to structural instability in the Bateman domain, which disrupts the intramolecular regulation. INTERPRETATION: Including 4 families with 3 new mutations, we describe a cohort of 12 kindreds with PRKAG2 syndrome with novel pathogenic mechanisms by computational modelling. Severe clinical cardiac phenotypes may be developed, including HF, requiring close follow-up.
29
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Bernard J. Gersh, Barry J. Maron, Robert O. Bonow et al. · Circulation · 2011 · 2.1K citations · Full text
New loci associated with kidney function and chronic kidney disease
Anna Köttgen, Cristian Pattaro, Carsten A. Böger et al. · Nature Genetics · 2010 · 810 citations · Full text
The role of endomyocardial biopsy in the management of cardiovascular disease
Leslie T. Cooper, Kenneth L. Baughman, Arthur M. Feldman et al. · European Heart Journal · 2007 · 467 citations
Medicine, Cardiology, Pediatrics +12